These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15884842)

  • 1. Low molecular weight polylactic acid as a matrix for the delayed release of pesticides.
    Zhao J; Wilkins RM
    J Agric Food Chem; 2005 May; 53(10):4076-82. PubMed ID: 15884842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
    Asmus LR; Kaufmann B; Melander L; Weiss T; Schwach G; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of in-vitro release characteristics of NSAID-loaded polylactic acid microspheres.
    Guiziou B; Armstrong DJ; Elliott PN; Ford JL; Rostron C
    J Microencapsul; 1996; 13(6):701-8. PubMed ID: 8933355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progresses on degradation mechanism in vivo and medical applications of polylactic acid].
    Liu JW; Zhao Q; Wan CX
    Space Med Med Eng (Beijing); 2001 Aug; 14(4):308-12. PubMed ID: 11681349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLA/PLGA nanoparticles for sustained release of docetaxel.
    Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
    Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of polylactic acid particles and release of fluorochromes upon topical application on human skin explants.
    Rancan F; Todorova A; Hadam S; Papakostas D; Luciani E; Graf C; Gernert U; Rühl E; Verrier B; Sterry W; Blume-Peytavi U; Vogt A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):76-84. PubMed ID: 21945270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):535-9. PubMed ID: 9876619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled drug release and hydrolysis mechanism of polymer-magnetic nanoparticle composite.
    Yang F; Zhang X; Song L; Cui H; Myers JN; Bai T; Zhou Y; Chen Z; Gu N
    ACS Appl Mater Interfaces; 2015 May; 7(18):9410-9. PubMed ID: 25881356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the recent developments in polylactide (PLA) research.
    Madhavan Nampoothiri K; Nair NR; John RP
    Bioresour Technol; 2010 Nov; 101(22):8493-501. PubMed ID: 20630747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hetero-stereocomplexes of D-poly(lactic acid) and the LHRH analogue leuprolide. Application in controlled release.
    Slager J; Domb AJ
    Eur J Pharm Biopharm; 2004 Nov; 58(3):461-9. PubMed ID: 15451519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro degradation behavior of a novel bioresorbable composite material based on PLA and a soluble CaP glass.
    Navarro M; Ginebra MP; Planell JA; Barrias CC; Barbosa MA
    Acta Biomater; 2005 Jul; 1(4):411-9. PubMed ID: 16701822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
    Wichert B; Rohdewald P
    J Microencapsul; 1993; 10(2):195-207. PubMed ID: 8392542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolytic degradation of films prepared from blends of high and low molecular weight poly(DL-lactic acid)s.
    Mauduit J; Pérouse E; Vert M
    J Biomed Mater Res; 1996 Feb; 30(2):201-7. PubMed ID: 9019485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dry method esterification of starch on the degradation characteristics of starch/polylactic acid composites.
    Zuo YF; Gu J; Qiao Z; Tan H; Cao J; Zhang Y
    Int J Biol Macromol; 2015 Jan; 72():391-402. PubMed ID: 25192854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing biodegradation of PLA and PLA-g-AA/starch films using a phosphate-solubilizing bacillus species.
    Wu CS
    Macromol Biosci; 2008 Jun; 8(6):560-7. PubMed ID: 18322910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics.
    Coowanitwong I; Arya V; Patel G; Kim WS; Craciun V; Rocca JR; Singh R; Hochhaus G
    J Pharm Pharmacol; 2007 Nov; 59(11):1473-84. PubMed ID: 17976257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles.
    Zhou MX; Chang TM
    J Microencapsul; 1988; 5(1):27-36. PubMed ID: 3199299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.